DE1910481A1 - Neue 3,3,5-Trimethylcyclohexylester und Verfahren zu ihrer Herstellung - Google Patents

Neue 3,3,5-Trimethylcyclohexylester und Verfahren zu ihrer Herstellung

Info

Publication number
DE1910481A1
DE1910481A1 DE19691910481 DE1910481A DE1910481A1 DE 1910481 A1 DE1910481 A1 DE 1910481A1 DE 19691910481 DE19691910481 DE 19691910481 DE 1910481 A DE1910481 A DE 1910481A DE 1910481 A1 DE1910481 A1 DE 1910481A1
Authority
DE
Germany
Prior art keywords
parts
weight
acid
mixture
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691910481
Other languages
German (de)
English (en)
Inventor
Masaru Hieda
Kenzo Kikuchi
Katsutada Masuda
Tai Matsuzawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE1910481A1 publication Critical patent/DE1910481A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE19691910481 1968-03-02 1969-03-01 Neue 3,3,5-Trimethylcyclohexylester und Verfahren zu ihrer Herstellung Pending DE1910481A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1373468 1968-03-02
JP4640568 1968-07-03

Publications (1)

Publication Number Publication Date
DE1910481A1 true DE1910481A1 (de) 1969-10-09

Family

ID=26349560

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691910481 Pending DE1910481A1 (de) 1968-03-02 1969-03-01 Neue 3,3,5-Trimethylcyclohexylester und Verfahren zu ihrer Herstellung

Country Status (4)

Country Link
BE (1) BE729170A (https=)
DE (1) DE1910481A1 (https=)
FR (1) FR2003097A1 (https=)
NL (1) NL6903138A (https=)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2007105049A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine derivatives as cetp inhibitors
WO2007105050A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1060356B (it) * 1973-03-12 1982-07-10 Poli Ind Chimica Spa Estere nicotinico e composizione farmaceutica ad azione vasodilata trice spasmolitica e ipolipemizzante e processo per la preparazione di detto estere
IT1137375B (it) * 1981-04-15 1986-09-10 Lab Farmaco Biolog Crosara S R Composto ad attivita' vasodilatatrice periferica utile come rubefacente, procedimento per la sua preparazione e composizioni farmaceutiche a base di detto composto

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2007105049A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine derivatives as cetp inhibitors
WO2007105050A1 (en) 2006-03-10 2007-09-20 Pfizer Products Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
EP4470609A2 (en) 2019-01-18 2024-12-04 Astrazeneca AB Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
NL6903138A (https=) 1969-09-04
FR2003097A1 (en) 1969-11-07
BE729170A (https=) 1969-08-01

Similar Documents

Publication Publication Date Title
DE1910481A1 (de) Neue 3,3,5-Trimethylcyclohexylester und Verfahren zu ihrer Herstellung
DE2356655B2 (de) Substituierte Phenoxy- a -methylpropionsäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2025624C2 (de) 5'-0-Ester von ara-Cytidin und Verfahren zu ihrer Herstellung
DE2305758C3 (https=)
DE2754654C2 (de) N-(3-Trifluormethylphenyl)-anthranilsäurealkylester, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
DE2403786A1 (de) Neue derivate der cumarine
EP0007347B1 (de) Lipidsenkende Alkylenglykolderivate und Verfahren zu ihrer Herstellung
DE3025804A1 (de) 1-s-alkyl-2-0-acyl-3-phosphocholin-1-mercapto-2,3-propandiole, verfahren zu deren herstellung und diese enthaltende arzneimittel
DD202431A5 (de) Verfahren zur herstellung von neuen freie carboxygruppen enthaltenden hexiten
DE3887612T2 (de) Salicylate, ihre Salze, diese enthaltende pharmazeutische Kompositionen und ihr Herstellungsverfahren.
CH420191A (de) Verfahren zur Herstellung von jodierten Acylaminobenzoesäureamiden und Verwendung derselben als schattengebende Komponente in Röntgenkontrastmitteln
DE1298981B (de) D-threo-1-Phenyl-2-amino-1, 3-propandiolderivate und Verfahren zu ihrer Herstellung
DE2245412C3 (de) 7-Chlor-5-phenyl-3-(3-carbamoyIpyridinium)-13-dihydro-2H-1,4-benzodiazepin-2-on halogenidverbindungen und Verfahren zur Herstellung derselben
CH637401A5 (de) Acylderivate der 2-(3-(2-chloraethyl)-3-nitrosoureido)-2-desoxy-d-glucopyranose.
DE2238304A1 (de) Choleretisch wirksame ester bzw. salze von gallensaeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2360475A1 (de) Spartein-derivate mit neuen pharmakologischen eigenschaften
DE1568206C (de) Neue Phosphorsäureester, Verfahren zu deren Herstellung, sowie insektizide und akarizide Mittel
DE2109855A1 (de) 1,6-disubstituierte 2,3-4,5-dianhydroiditderivate,ihre verwendung und verfahren zur herstellung derselben
AT262962B (de) Verfahren zur Herstellung neuer Cyclopropancarbonsäureester
AT227720B (de) Verfahren zur Herstellung von neuen Phosphorsäureestern
DE2218547A1 (de) Verfahren zur herstellung von 4eckige klammer auf bis-(2-chloraethyl)amino eckige klammer zu -2,3-dimethyl-1phenyl-pyrazolon-(5)
DE2357069C3 (de) D-GIu caro-1,5-lactam-alkylester
DE1804392A1 (de) 9-0-Kalamycinderivate und Verfahren zu ihrer Herstellung
DE1695363C3 (de) 1H-3.4 Dihydro-2,3 benzoxazin und dessen substituierte Derivate sowie Verfahren zur Herstellung dieser Verbindungen
AT230378B (de) Verfahren zur Herstellung von neuen diquartären α,ω-Bis-[pyridyl-(4)-thio]-alkanen und -dialkyläthern